We are live on ! Find out more
Russell Investments Group

Russell Investments Group Portfolio holdings

AUM $114B
1-Year Est. Return 41.71%
This Fund
S&P 500
This Quarter Est. Return
-2.23%
1 Year Est. Return
+41.71%
3 Year Est. Return
+123.74%
5 Year Est. Return
+158.32%
10 Year Est. Return
AUM
$50.5B
AUM Growth
-$1.34B
Cap. Flow
+$1.28B
Cap. Flow %
2.53%
Top 10 Hldgs %
18.52%
Holding
3,698
New
240
Increased
1,487
Reduced
1,442
Closed
184

Sector Composition

Rank Sector Weight
1 Technology 21.93%
2 Financials 12.79%
3 Healthcare 12.23%
4 Consumer Discretionary 9.82%
5 Real Estate 8.87%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SVRN
3101
OceanPal Inc
SVRN
$12.1M
0
TMCI icon
3102
Treace Medical Concepts
TMCI
$308M
$223 ﹤0.01%
17
-283,174
-100% -$5.18M
XERS icon
3103
Xeris Biopharma Holdings
XERS
$1.53B
$221 ﹤0.01%
+119
New +$273
NOVA
3104
DELISTED
Sunnova Energy
NOVA
$220 ﹤0.01%
21
+1
+5% +$16
OVID icon
3105
Ovid Therapeutics
OVID
$482M
$219 ﹤0.01%
+57
New +$205
ETNB
3106
DELISTED
89bio
ETNB
$216 ﹤0.01%
14
-5,086
-100% -$85.4K
QNST icon
3107
QuinStreet
QNST
$1.2B
$215 ﹤0.01%
24
-48,658
-100% -$450K
CABA icon
3108
Cabaletta Bio
CABA
$455M
$213 ﹤0.01%
+14
New +$191
KRMD icon
3109
KORU Medical Systems
KRMD
$159M
$211 ﹤0.01%
+78
New +$214
EBIX
3110
DELISTED
Ebix Inc
EBIX
$207 ﹤0.01%
21
-1,253
-98% -$24.4K
HRTX icon
3111
Heron Therapeutics
HRTX
$61.3M
$206 ﹤0.01%
+200
New +$285
MNSB icon
3112
MainStreet Bancshares
MNSB
$174M
$205 ﹤0.01%
+10
New +$229
FDMT icon
3113
4D Molecular Therapeutics
FDMT
$600M
$204 ﹤0.01%
16
-1,110
-99% -$18.6K
BW icon
3114
Babcock & Wilcox
BW
$1.37B
$202 ﹤0.01%
+48
New +$251
PTGX icon
3115
Protagonist Therapeutics
PTGX
$9.6B
$200 ﹤0.01%
12
-43,510
-100% -$844K
GNLX icon
3116
Genelux
GNLX
$119M
$196 ﹤0.01%
+8
New +$203
TPIC
3117
DELISTED
TPI Composites
TPIC
$188 ﹤0.01%
+71
New +$434
NKLA
3118
DELISTED
Nikola Corporation Common Stock
NKLA
$177 ﹤0.01%
4
BCML icon
3119
BayCom
BCML
$341M
$173 ﹤0.01%
9
ORIC icon
3120
Oric Pharmaceuticals
ORIC
$1.42B
$169 ﹤0.01%
+28
New +$229
UHT
3121
Universal Health Realty Income Trust
UHT
$566M
$162 ﹤0.01%
4
LLAP
3122
DELISTED
Terran Orbital Corporation
LLAP
$160 ﹤0.01%
192
-1,344
-88% -$1.78K
RLMD icon
3123
Relmada Therapeutics
RLMD
$477M
$159 ﹤0.01%
53
GCBC icon
3124
Greene County Bancorp
GCBC
$593M
$144 ﹤0.01%
6
TRDA icon
3125
Entrada Therapeutics
TRDA
$274M
$142 ﹤0.01%
9
-6,744
-100% -$106K

Similar funds

Russell Investments Group's Q3 2023 Portfolio in Review

As of Q3 2023, Russell Investments Group held 3,698 positions worth $50.5B, down 2.6% from $51.8B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Russell Investments Group's Q3 2023 filing shows 240 new, 1,487 increased, 1,442 reduced and 184 closed positions. Its largest new stake was Apollo Global Management Series A: 4,864,000 shares worth $5.36M. The largest sale was iShares Core S&P 500 ETF, an estimated $83.4M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 22% a quarter earlier, followed by Financials and Healthcare.

  • Russell Investments Group's largest Q3 2023 buy was Apollo Global Management Series A: 4,864,000 shares worth $5.36M.
  • Russell Investments Group added most to Bank of America Series L in Q3 2023, an estimated $406M increase.
  • Russell Investments Group's biggest Q3 2023 reduction was iShares Core S&P 500 ETF, cutting an estimated $83.4M.
  • Russell Investments Group fully exited Life Storage, Inc. in Q3 2023, selling an estimated $49.6M.
  • Russell Investments Group's ten largest holdings make up 19% of its $50.5B portfolio in Q3 2023.
  • Russell Investments Group opened 240 new positions and closed 184 in Q3 2023.
  • Russell Investments Group's portfolio value fell 2.6% quarter-over-quarter to $50.5B.

Based on Russell Investments Group's 13F filing for Q3 2023, filed 13 Nov 2023.